|
|
Volumn 6, Issue 9, 2000, Pages 955-960
|
|
Is the development of a new tuberculosis vaccine possible?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCG VACCINE;
CYTOKINE;
CYTOLYSIN;
ETHAMBUTOL;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ISONIAZID;
MALARIA VACCINE;
PYRAZINAMIDE;
RIFAMPICIN;
STREPTOMYCIN;
TUBERCULOSTATIC AGENT;
ARTICLE;
BUDGET;
DRUG RESEARCH;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
MALARIA;
MOUSE;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PRIORITY JOURNAL;
SIDE EFFECT;
TUBERCULOSIS;
TUBERCULOSIS CONTROL;
VACCINE PRODUCTION;
ANTITUBERCULAR AGENTS;
BCG VACCINE;
DISEASE MODELS, ANIMAL;
MODELS, IMMUNOLOGICAL;
MYCOBACTERIUM TUBERCULOSIS;
TECHNOLOGY, PHARMACEUTICAL;
TUBERCULOSIS;
WORLD HEALTH;
WORLD HEALTH ORGANIZATION;
|
|
EID: 0033826580
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/79631 Document Type: Article |
|
Times cited : (210)
|
|
References (0)
|
